Evidence map›Paper›PMID 33040062›Full record

ArticleEuropean addiction research2021

Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study.

Roman Gabrhelík, Milada Mahic, Ingunn Olea Lund, Jørgen Bramness, Randi Selmer, Eva Skovlund, Marte Handal, Svetlana Skurtveit

Abstract read
In one paragraph

Article in European addiction research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Cannabis use and cannabis use disorders and their treatment in the Europe.European archives of psychiatry and clinical neuroscience · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Substance and alcohol use in pregnant women attending antenatal care at a tertiary hospital in Johannesburg, South Africa.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roman GabrhelíkDepartment of Addictology, First Faculty of Medicine, Charles University, Prague, Czechia, roman.gabrhelik@lf1.cuni.cz.
Milada MahicNorwegian Institute of Public Health, Oslo, Norway.
Ingunn Olea LundNorwegian Institute of Public Health, Oslo, Norway.
Jørgen BramnessNorwegian Institute of Public Health, Oslo, Norway.
Randi SelmerNorwegian Institute of Public Health, Oslo, Norway.
Eva SkovlundNorwegian Institute of Public Health, Oslo, Norway.
Marte HandalNorwegian Institute of Public Health, Oslo, Norway.
Svetlana SkurtveitNorwegian Institute of Public Health, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith recent changes in legislation regulating recreational and medical cannabis use around the globe, increased use in pregnancy is to be expected.

objectivesTo investigate the association between cannabis use during pregnancy and birth outcomes.

methodData from the Norwegian Mother and Child Cohort Study (MoBa), a prospective pregnancy cohort, were used. Participants were recruited from all over Norway between 1999 and 2008: 9,312 women with 10,373 pregnancies who reported use of cannabis before or in pregnancy. Women reported on their illegal drug use before pregnancy and at pregnancy weeks 17/18 and 30 and at 6 months postpartum. Linear regression was used to estimate crude and adjusted effects of prenatal cannabis exposure on birth outcomes.

resultsIn 10,101 pregnancies, women had used cannabis before pregnancy but not during pregnancy. In 272 pregnancies, women had used cannabis during pregnancy, and among these, in 63 pregnancies, women had used cannabis in at least 2 periods. In adjusted analyses for potential confounders, only cannabis use during at least 2 periods of pregnancy showed statistically significant effects on birth weight. The effect was observed in the complete cohort (B = -228 g, 95% CI = -354 to -102, p < 0.001) and for the subgroup where information about the child's father was available (B = -225 g, 95% CI = -387 to -63, p = 0.01). Our results may indicate that prolonged use causes more harm, whereas short-term use did not indicate adverse effects on birth outcomes.

conclusionsThere was a statistically significant and clinically relevant association between the use of cannabis during pregnancy and reduced birth weight. Clinicians should screen not only for cannabis use but also for the length and intensity of use as part of a comprehensive substance use screening.

Indexed as

CannabisFemaleHumansLongitudinal StudiesNorwayPregnancyPregnancy OutcomeProspective StudiesBirth outcomeCannabisCohortMoBaPregnancyProspective

Identifiers

PMID33040062
PMCPMC8006586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.